Syndrome of Inappropriate Antidiuretic Hormone (SIADH)
18 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the primary physiological mechanism responsible for the fluid retention seen in SIADH?

  • Decreased production of aldosterone
  • Increased renal excretion of sodium
  • Enhanced permeability of the renal collecting duct to water (correct)
  • Impaired thirst sensation
  • Which of the following is NOT a common clinical manifestation of SIADH?

  • Hypokalemia
  • Headache
  • Hyponatremia
  • Increased urine output (correct)
  • Which one of the following conditions is most commonly associated with SIADH?

  • Hypothyroidism
  • Hypertension
  • Cancer, particularly small cell lung cancer (correct)
  • Diabetes insipidus
  • What laboratory finding confirms the diagnosis of SIADH?

    <p>Low serum osmolality and high urine osmolality (B)</p> Signup and view all the answers

    What is the typical effect of SIADH on glomerular filtration rate?

    <p>Increases (D)</p> Signup and view all the answers

    Why is SIADH more likely to be self-limiting when caused by head trauma or drugs?

    <p>The injury or drug effect is temporary (D)</p> Signup and view all the answers

    Which of the following clinical manifestations of SIADH may occur as serum sodium levels fall below 120 mEq/L?

    <p>Muscle twitching (C)</p> Signup and view all the answers

    What is the primary nursing intervention for a patient with SIADH?

    <p>Restricting fluid intake (C)</p> Signup and view all the answers

    What is the recommended fluid restriction for patients with mild hyponatremia and a serum sodium level greater than 125 mEq/L?

    <p>800 to 1000 mL/day (A)</p> Signup and view all the answers

    Which of the following medications should be avoided or discontinued in patients with SIADH?

    <p>Medications that stimulate ADH release (C)</p> Signup and view all the answers

    What is the recommended treatment for severe hyponatremia (less than 120 mEq/L) with neurologic manifestations, such as seizures?

    <p>IV hypertonic saline solution (B)</p> Signup and view all the answers

    What is the maximum rate of increase in serum sodium level recommended in the first 24 hours when treating hyponatremia?

    <p>8 to 12 mEq/L (D)</p> Signup and view all the answers

    Which of the following is a possible complication of rapidly correcting hyponatremia?

    <p>Osmotic demyelination syndrome (A)</p> Signup and view all the answers

    What is the recommended fluid restriction for patients with chronic SIADH?

    <p>800 to 1000 mL/day (B)</p> Signup and view all the answers

    Which of the following drugs is NOT approved for use in the United States to treat euvolemic hyponatremia?

    <p>Desmopressin (D)</p> Signup and view all the answers

    Which of the following conditions is NOT a potential cause of SIADH listed in Table 54.3?

    <p>Diabetes mellitus (A)</p> Signup and view all the answers

    Which of the following medications can cause SIADH?

    <p>Oxytocin (B)</p> Signup and view all the answers

    Besides loop diuretics, which electrolyte may need to be supplemented for patients with SIADH, especially if taking loop diuretics?

    <p>Potassium (B)</p> Signup and view all the answers

    Study Notes

    Syndrome of Inappropriate Antidiuretic Hormone (SIADH)

    • Etiology and Pathophysiology: SIADH is caused by excessive antidiuretic hormone (ADH) production despite normal or low plasma osmolarity. ADH increases kidney water reabsorption, leading to fluid retention, decreased plasma osmolality, increased glomerular filtration rate, and dilutional hyponatremia. Features include fluid retention, low serum osmolality, low sodium (hyponatremia), low chloride (hypochloremia), and concentrated urine.

    • Common Causes: Cancer, especially small cell lung cancer, is the most frequent cause. Other causes include head trauma or drug use (often self-limiting) and tumors or other metabolic diseases (often chronic).

    • Clinical Manifestations: Early symptoms include thirst, dyspnea, fatigue, and mild hyponatremia (muscle cramping, irritability, headaches). Severe hyponatremia (typically <120 mEq/L) results in vomiting, abdominal cramps, muscle twitching, lethargy, confusion, seizures, and coma due to cerebral edema. Low urine output and increased body weight are also present.

    • Diagnosis: SIADH is diagnosed by comparing urine and serum osmolality. Dilutional hyponatremia is characterized by serum sodium <135 mEq/L, serum osmolality <280 mOsm/kg, and urine specific gravity >1.030. A serum osmolality significantly lower than urine osmolality indicates inappropriate urine concentration despite dilute serum.

    Interprofessional and Nursing Care

    • Assessment: Patients at risk for or with confirmed SIADH should be assessed for low urine output with high specific gravity, sudden weight gain without edema, or decreased serum sodium. Monitor intake/output, vital signs, cardiac/pulmonary sounds, and obtain daily weights.

    • Monitoring: Observe for symptoms of hyponatremia such as seizures, headache, vomiting, and decreased neurological function.

    • Treatment (Mild Cases): If symptoms are mild and serum sodium is >125 mEq/L, fluid restriction to 800-1000 mL/day may be the only treatment. This aims to reduce fluid overload, increasing serum sodium and osmolality. Oral care and distractions to cope with thirst from restriction are helpful.

    • Treatment (Moderate Cases): Loop diuretics (e.g., furosemide) may be used to promote diuresis, but serum sodium must be at least 125 mEq/L. Potassium, calcium, and magnesium supplements may be needed due to diuretic effects. Demeclocycline can also be used to block ADH effect on the kidneys.

    • Treatment (Severe Cases): For severe hyponatremia (<120 mEq/L) with neurological symptoms, IV hypertonic saline (3% sodium chloride) is given very cautiously. Sodium levels should not increase by more than 8-12 mEq/L per 24 hours to prevent osmotic demyelination syndrome. Additional fluid restriction (500 mL/day) may be required in severe cases.

    • Vasopressin Receptor Antagonists: For euvolemic hyponatremia in hospitalized patients, vasopressin receptor antagonists (conivaptan or tolvaptan) can be used to block the activity of ADH. These drugs should be avoided in liver disease, as they can worsen liver function.

    • Chronic Management: Encourage self-management in patients with chronic SIADH. Recommend a fluid restriction of 800-1000 mL/day. Offer alternative thirst relief measures (ice chips, sugarless gum). Teach the importance of supplementing sodium and potassium intake, especially if using loop diuretics, and the need for daily weight monitoring. Inform them about symptoms of fluid and electrolyte imbalances.

    • General Precautions: In patients with alteration in sensorium or seizures, initiate seizure and fall precautions. Maintain the head of the bed flat or elevated no more than 10 degrees to promote venous return. Promote skin and joint integrity with frequent turning, repositioning, and range-of-motion exercises.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Description

    This quiz covers the etiology, pathophysiology, and clinical manifestations of the Syndrome of Inappropriate Antidiuretic Hormone (SIADH). It explores common causes, including cancer and head trauma, as well as the impact of SIADH on serum osmolarity and sodium levels. Test your knowledge about this important endocrinological condition.

    More Like This

    Use Quizgecko on...
    Browser
    Browser